Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansell

Showing results (101-110 of 2,414) with videos related to

Pageof 242
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2020
Fundamentals of immunology for understanding immunotherapy for lymphomaStephen M Ansell
Hematology/Oncology Clinics of North America|November 30, 2013
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse)Stephen M Ansell
American Journal of Hypertension|October 26, 2005
Evidence for a combined approach to the management of hypertension and dyslipidemiaBenjamin J Ansell
Blood|March 21, 2015
DNA methylation in lymphoma: an opportunity?Stephen M Ansell
Current Atherosclerosis Reports|December 17, 2008
A review of trials evaluating nonstatin lipid-lowering therapiesBenjamin J Ansell
The Journal of Rheumatology. Supplement|June 1, 1987
Perspectives in pediatric systemic lupus erythematosusB M Ansell
Clinical and Experimental Rheumatology|November 1, 1994
Reactive arthritis/Reiter's syndrome in childrenB M Ansell
The Lancet. Haematology|January 8, 2019
Sintilimab: another effective immune checkpoint inhibitor in classical Hodgkin lymphomaStephen M Ansell
Blood Advances|November 24, 2020
Fundamentals of immunology for understanding immunotherapy for lymphomaStephen M Ansell
Journal of Oncology Practice|February 13, 2016
Where Do Programmed Death-1 Inhibitors Fit in the Management of Malignant Lymphoma?Stephen M Ansell
Pageof 242

Showing results (101-110 of 2,414) with videos related to

Sort By:
Pageof 242
Hematology. American Society of Hematology. Education Program|December 4, 2020
Fundamentals of immunology for understanding immunotherapy for lymphomaStephen M Ansell
Hematology/Oncology Clinics of North America|November 30, 2013
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse)Stephen M Ansell
American Journal of Hypertension|October 26, 2005
Evidence for a combined approach to the management of hypertension and dyslipidemiaBenjamin J Ansell
Blood|March 21, 2015
DNA methylation in lymphoma: an opportunity?Stephen M Ansell
Current Atherosclerosis Reports|December 17, 2008
A review of trials evaluating nonstatin lipid-lowering therapiesBenjamin J Ansell
The Journal of Rheumatology. Supplement|June 1, 1987
Perspectives in pediatric systemic lupus erythematosusB M Ansell
Clinical and Experimental Rheumatology|November 1, 1994
Reactive arthritis/Reiter's syndrome in childrenB M Ansell
The Lancet. Haematology|January 8, 2019
Sintilimab: another effective immune checkpoint inhibitor in classical Hodgkin lymphomaStephen M Ansell
Blood Advances|November 24, 2020
Fundamentals of immunology for understanding immunotherapy for lymphomaStephen M Ansell
Journal of Oncology Practice|February 13, 2016
Where Do Programmed Death-1 Inhibitors Fit in the Management of Malignant Lymphoma?Stephen M Ansell
Pageof 242